The acquisition of TriviumVet brings the addition of an innovative new product, Felycin®-CA1, to the PRN® Pharmacal portfolio of products. Felycin is the only FDA conditionally approved drug for the management of ventricular hypertrophy in cats with subclinical hypertrophic cardiomyopathy (HCM), one of the most common and life-threatening diseases in cats. TriviumVet adds … [Read more...]
Sponsored Content – Separation anxiety CE from PRN University
PRN® Pharmacal's UniversityPRN.com < link > announced a new 1-hour CE course on Separation Anxiety written by Boarded Behaviorist Dr. Debra Horwitz. During the course participants will learn to: Recognize the signs of separation anxiety in dogs Inquire about the symptoms, triggers and risk factors Identify differential and co-morbid diagnoses Recommend … [Read more...]